Author/year | Country | Data sources | Sample size | Age (years) | Eligibility criteria | Study period | Settings | Stroke stage |
---|---|---|---|---|---|---|---|---|
Sico/2017 [23] | America | Randomized trials | 303 | Development: 70.8 ± 9.9 Validation: 60.7 ± 9.9 | Patient with ischemic stroke; history with hypertension | 2004–2008 | Hospital | Acute or subacute |
Brown/2020 [25] | America | Cross-sectional study | 1330 | 65.0 ±12.6 | Patients with stroke; ≥ 45 years old | 2010–2018 | Acute care hospital | Acute |
Boulos/2019 [29] | Canada | Cross-sectional study | 231 | 64.4 ± 15.3 | Outpatients with ischemic Stroke; English speaking; | 4/2011–7/2017 | Stroke prevention clinic | No restriction |
Katzan/2016 [27] | America | Retrospective cohort | 208 | 55.4 ± 14.1 | Patients with stroke | 1/2011–12/2012 | Cerebrovascular clinic | No restriction |
Bernardini/2021 [21] | Italy | Cross-sectional study | 30 | Not mentioned | Patient with cerebrovascular event | 8/2019–7/2020 | Stroke unit | Acute |
Zhang/2019 [22] | China | Cross-sectional study | 124 | 62.6 ± 12.6 | Patients with stroke | 6/2016–5/2017 | Neurology unit | Acute |
Boulos/2016 [24] | Canada | Cross-sectional study | 69 | 68.3 ± 14.2 | Patients with stroke (ischemic or hemorrhagic) | 7/2014–6/2015 | Stroke unit or stroke prevention clinic | Acute and subacute |
Petrie/2021 [26] | America | Retrospective cohort | 344 | 59.0 ± 11.8 | Patients with acute stroke, subarachnoid hemorrhage | 10/2014–10/2015 | Stroke unit | Acute |
Šiarnik/2020 [31] | Slovakia | Cross-sectional study | 120 | Development: 67.2 ± 9.1 Validation: 62.4 ± 13.3 | Patients with acute ischemic stroke | Not mentioned | Stroke unit | Acute |
Camilo/2014 [28] | Brazil | Cross-sectional study | 39 | 63.2 ± 12.2 | Patients with first ischemic stroke > 18 years old | Not mentioned | Emergency unit | Acute |
Srijithesh/2011 [30] | India | Cross-sectional study | 39 | 56.5 | Patients with hemorrhagic or ischemic stroke | Not mentioned | Neurology unit | Subacute |